Champions Oncology (CSBR) Leases (2016 - 2026)
Champions Oncology (CSBR) has 14 years of Leases data on record, last reported at $4.3 million in Q4 2025.
- For Q4 2025, Leases rose 1368.92% year-over-year to $4.3 million; the TTM value through Oct 2025 reached $4.3 million, up 1368.92%, while the annual FY2025 figure was $220000.0, 96.48% down from the prior year.
- Leases reached $4.3 million in Q4 2025 per CSBR's latest filing, down from $4.8 million in the prior quarter.
- Across five years, Leases topped out at $8.0 million in Q3 2022 and bottomed at $220000.0 in Q2 2025.
- Average Leases over 5 years is $2.4 million, with a median of $1.0 million recorded in 2023.
- Peak YoY movement for Leases: soared 8475.0% in 2021, then plummeted 96.48% in 2025.
- A 5-year view of Leases shows it stood at $343000.0 in 2021, then surged by 220.7% to $1.1 million in 2022, then decreased by 9.09% to $1.0 million in 2023, then tumbled by 70.4% to $296000.0 in 2024, then skyrocketed by 1368.92% to $4.3 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $4.3 million in Q4 2025, $4.8 million in Q3 2025, and $220000.0 in Q2 2025.